To make improvements to the Children's Gasoline Burn Prevention Act.

Issues related to implementation of the Consumer Product Safety Improvement Act; HR 6065 - regulation of portable fuel containers

Client expense: $1,010,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Equal Employment Opportunity Commission (EEOC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Labor Relations Board (NLRB), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

H.R.6065-A bill to make improvements to the Children's Burn Prevention Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE

H.R.1873/S.987 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts. H.R.6351 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. Lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. S.1946/H.R.3646 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. S.3076/H.R.4369 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. S.2295/H.R.4384 (Patient Safety and Generic Labeling Improvement Act); to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand name drug manufactuers to do so. H.R.6065 (no short title); to make improvements to the Children's Gasoline Burn Prevention Act; specific interest in provisions to limit the liability of gasoline container manufacturers. H.R. 6584 (Verifying Authority and Legality In Drug Compounding Act of 2012), to amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products; specific interest in preservation of state-based causes of action. General lobbying with regard to the regulation of compoudning pharmacies and preservation of state-based causes of action. S.1223 (Location Privacy Protection Act of 2012); to address voluntary location tracking of electronic communications devices; specific interest in creation of enforcement actions and Grassley Amendment (failed in Committee) to require transparency for outside counsel retained by State Attorneys General.

Client expense: $790,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office